Variant report
Variant | nsv980458 |
---|---|
Chromosome Location | chr4:91639363-91644810 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr4:91643291..91645856-chr4:91647962..91650916,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs185533589 | chr4:91640208-91640209 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs566043069 | chr4:91640209-91640210 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs368635278 | chr4:91640217-91640218 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs577488308 | chr4:91640220-91640221 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs554886416 | chr4:91640244-91640245 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs542568895 | chr4:91640285-91640286 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs386677199 | chr4:91640293-91640294 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs146034135 | chr4:91640294-91640295 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs116637049 | chr4:91640298-91640299 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs114359188 | chr4:91640299-91640300 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs544682775 | chr4:91640300-91640301 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs564860403 | chr4:91640301-91640302 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs527412492 | chr4:91640344-91640345 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs531656127 | chr4:91640346-91640347 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs189239932 | chr4:91640372-91640373 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs374144987 | chr4:91640379-91640380 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs550139950 | chr4:91640392-91640393 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs564140431 | chr4:91643806-91643807 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs532777952 | chr4:91643819-91643820 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs546724837 | chr4:91643821-91643822 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs566234992 | chr4:91643884-91643885 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs147905775 | chr4:91643896-91643897 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs548782985 | chr4:91643897-91643898 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs568684232 | chr4:91643899-91643900 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs17017458 | chr4:91643922-91643923 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs557752479 | chr4:91643928-91643929 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs139925152 | chr4:91644044-91644045 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs533943398 | chr4:91644045-91644046 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs62314446 | chr4:91644049-91644050 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs17017459 | chr4:91644155-91644156 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs17017461 | chr4:91644263-91644264 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs556822284 | chr4:91644282-91644283 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs182314199 | chr4:91644293-91644294 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs369769338 | chr4:91644307-91644308 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs78126427 | chr4:91644311-91644312 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs555997029 | chr4:91644317-91644318 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs565439066 | chr4:91644328-91644329 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs74786514 | chr4:91644339-91644340 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs539859101 | chr4:91644416-91644417 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs370347900 | chr4:91644443-91644444 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs186624313 | chr4:91644475-91644476 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs536092114 | chr4:91644538-91644539 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs548646942 | chr4:91644621-91644622 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs528666447 | chr4:91644624-91644625 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs374344078 | chr4:91644635-91644636 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs531395753 | chr4:91644679-91644680 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs551507237 | chr4:91644703-91644704 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs571460345 | chr4:91644715-91644716 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs9790424 | chr4:91644724-91644725 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs554228186 | chr4:91644748-91644749 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Parkinson disease | 18923514 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16272173 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Lung cancer | 18438408 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Autism | 18414403 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Mental retardation | 20522426 | CNVD |
delayed speech | 20522426 | CNVD |
growth disorder | 20522426 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17133270 | CNVD |
Colorectal cancer | 20459617 | CNVD |
Acute monocytic leukemia | 16498392 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Parkinson disease | 20877625 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Breast cancer | 17393978 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Obesity | 20622171 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Cancer | 20164920 | CNVD |
Cancer | 20164919 | CNVD |
Breast cancer | 22522925 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:91640200-91640400 | Enhancers | Pancreas | Pancrea |
2 | chr4:91643800-91644200 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
3 | chr4:91643800-91646200 | Enhancers | HUES64 Cell Line | embryonic stem cell |
4 | chr4:91644000-91644400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
5 | chr4:91644000-91644600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
6 | chr4:91644200-91644600 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
7 | chr4:91644200-91649200 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
8 | chr4:91644400-91645600 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
9 | chr4:91644600-91644800 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
10 | chr4:91644600-91648600 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
11 | chr4:91644800-91648600 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |